Latest News & Features
Generics
Otsuka Pharmaceuticals has filed a patent infringement suit against MSN Laboratories targeting the company’s planned generic Samsca heart medication. 15 March 2022
Americas
A California court has given a partial win to MedImpact in a trade secrets suit against US data giant IQVIA over its medical insurance platform. 15 March 2022
Generics
AbbVie and Icelandic biosimilar company Alvotech have settled all US litigation over Alvotech’s proposed generic of AbbVie’s blockbuster arthritis treatment Humira (adalimumab). 10 March 2022
Americas
A subsidiary of Tokyo-based FujiFilm has announced that it has filed a patent infringement lawsuit against ultrasound machine maker Butterfly Network. 10 March 2022
Americas
K&L Gates has hired two life science partners, Hannah Koyfman and David Lu, and their 10-person team to bolster the firm's nascent Boston practice. 10 March 2022
Generics
Mumbai-based pharma company Cipla has filed a lawsuit asking a Delaware court to rule that its proposed generic of Boehringer Ingelheim’s lung disease treatment Ofev does not infringe two patents. 8 March 2022
Big Pharma
Moderna has stated that it will “never” enforce its COVID-19 patents in 92 low and middle-income countries. 8 March 2022
Big Pharma
Regeneron has failed to convince a Manhattan district court to drop a lawsuit claiming that it developed COVID-19 treatments using Allele’s fluorescent protein invention without its permission. 7 March 2022
Americas
The US Chamber of Commerce has warned against the proposed Covid-19 IP waiver, in its latest International IP Index, a report measuring the quality of global IP systems. 3 March 2022
Biotechnology
Harvard College and 10x Genomics have sued Nanostring Technologies, alleging that the company’s CosMx imaging platform infringes two patents covering “gene-mapping” technology. 3 March 2022